Skip to main content
NCBI home page
Medical History logoLink to Medical History
. 2003 Jul;47(3):332–356.

Part of a scientific master plan? Paul Ehrlich and the origins of his receptor concept.

Cay-Rüdiger Prüll 1
PMCID: PMC1044632  PMID: 12905918

Full text

PDF
332

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bynum W. F. Chemical structure and pharmacological action: a chapter in the history of 19th century molecular pharmacology. Bull Hist Med. 1970 Nov-Dec;44(6):518–538. [PubMed] [Google Scholar]
  2. Cambrosio A., Jacobi D., Keating P. Ehrlich's "beautiful pictures" and the controversial beginnings of immunological imagery. Isis. 1993 Dec;84(4):662–699. doi: 10.1086/356636. [DOI] [PubMed] [Google Scholar]
  3. Classen M., Franken F. H., Gericke D. Friedrich Theodor Frerichs in Berlin. Dtsch Med Wochenschr. 1995 Sep 29;120(39):1334–1337. doi: 10.1055/s-0029-1233930. [DOI] [PubMed] [Google Scholar]
  4. Crist E., Tauber A. I. Debating humoral immunity and epistemology: the rivalry of the immunochemists Jules Bordet and Paul Ehrlich. J Hist Biol. 1997 Fall;30(3):321–356. doi: 10.1023/a:1004269605715. [DOI] [PubMed] [Google Scholar]
  5. Elkeles B. Medizinische Menschenversuche gegen Ende des 19. Jahrhunderts und der Fall Neisser. Medizinhist J. 1985;20(1-2):135–148. [PubMed] [Google Scholar]
  6. GUNTHER O. Immunitätstheorien; von der Seitenkettentheorie zur Fliessbandtheorie. Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M. 1954;51:69–107. [PubMed] [Google Scholar]
  7. Gradmann C. Money and microbes: Robert Koch, tuberculin and the Foundation of the Institute for Infectious Diseases in Berlin in 1891. Hist Philos Life Sci. 2000;22(1):59–79. [PubMed] [Google Scholar]
  8. Hopkins J. S. Partnership in patients. Perspectives must be reconciled. BMJ. 2000 Jan 8;320(7227):118–118. [PubMed] [Google Scholar]
  9. JOKL E. Paul Ehrlich; man and scientist. Bull N Y Acad Med. 1954 Dec;30(12):968–975. [PMC free article] [PubMed] [Google Scholar]
  10. KLOSE F. Paul Ehrlich und Emil von Behring; zur hundertjährigen Wiederkehr ihrer Geburtstage am 14. und 15. März 1954. Dtsch Med Wochenschr. 1954 Mar 12;79(11):425–427. doi: 10.1055/s-0028-1115447. [DOI] [PubMed] [Google Scholar]
  11. Liebenau J. Paul Ehrlich as a commercial scientist and research administrator. Med Hist. 1990 Jan;34(1):65–78. doi: 10.1017/s0025727300050274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Maulitz R. C. Rudolf Virchow, Julius Cohnheim and the program of pathology. Bull Hist Med. 1978 Summer;52(2):162–182. [PubMed] [Google Scholar]
  13. Mazumdar P. M. The antigen-antibody reaction and the physics and chemistry of life. Bull Hist Med. 1974 Spring;48(1):1–21. [PubMed] [Google Scholar]
  14. Münch R., Biel S. S. Expedition, Experiment und Expertise im Spiegel des Nachlasses von Robert Koch. Sudhoffs Arch. 1998;82(1):1–29. [PubMed] [Google Scholar]
  15. Parascandola J., Jasensky R. Origins of the receptor theory of drug action. Bull Hist Med. 1974 Summer;48(2):199–220. [PubMed] [Google Scholar]
  16. Parascandola J. The controversy over structure activity relationships in the early twentieth century. Pharm Hist. 1974;16:54–63. [PubMed] [Google Scholar]
  17. Parascandola J. The theoretical basis of Paul Ehrlich's chemotherapy. J Hist Med Allied Sci. 1981 Jan;36(1):19–43. doi: 10.1093/jhmas/xxxvi.1.19. [DOI] [PubMed] [Google Scholar]
  18. Rubin L. P. Styles in scientific explanation: Paul Ehrlich and Svante Arrhenius on Immunochemistry. J Hist Med Allied Sci. 1980 Oct;35(4):397–325. doi: 10.1093/jhmas/xxxv.4.397. [DOI] [PubMed] [Google Scholar]
  19. Schlich T. Linking cause and disease in the laboratory: Robert Koch's method of superimposing visual and 'functional' representations of bacteria. Hist Philos Life Sci. 2000;22(1):43–58. [PubMed] [Google Scholar]
  20. Schmiedebach H. P. The Prussian state and microbiological research--Friedrich Loeffler and his approach to the "invisible" virus. Arch Virol Suppl. 1999;15:9–23. doi: 10.1007/978-3-7091-6425-9_2. [DOI] [PubMed] [Google Scholar]
  21. Silverstein A. M. Pasteur, Pastorians, and the dawn of immunology: the importance of specificity. Hist Philos Life Sci. 2000;22(1):29–41. [PubMed] [Google Scholar]
  22. Travis A. S. Science as receptor of technology: Paul Ehrlich and the synthetic dyestuffs industry. Sci Context. 1989 Autumn;3(2):383–408. doi: 10.1017/s0269889700000879. [DOI] [PubMed] [Google Scholar]
  23. WITEBSKY E. Ehrlich's side-chain theory in the light of present immunology. Ann N Y Acad Sci. 1954 Sep;59(2):168–181. doi: 10.1111/j.1749-6632.1954.tb45929.x. [DOI] [PubMed] [Google Scholar]

Articles from Medical History are provided here courtesy of Cambridge University Press

RESOURCES